LISATA THERAPEUTICS, INC. Diluted Shares Outstanding (Weighted Average)
LISATA THERAPEUTICS, INC. (LSTA) reported Diluted Shares Outstanding (Weighted Average) of 9.11 million shares for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Income Statement › Earnings Per Share
us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding · last filed 2026-08-06
- LISATA THERAPEUTICS, INC. weighted average number of shares outstanding, diluted for the quarter ending 2026-06-30 was 9.11M shares, a 5.82% increase year-over-year.
- LISATA THERAPEUTICS, INC. weighted average number of shares outstanding, diluted for the quarter ending 2026-03-31 was 9.01M shares, a 4.70% increase year-over-year.
- LISATA THERAPEUTICS, INC. weighted average number of shares outstanding, diluted for the quarter ending 2025-12-31 was 8.80M shares, a 4.84% increase year-over-year.
- LISATA THERAPEUTICS, INC. weighted average number of shares outstanding, diluted for the quarter ending 2025-09-30 was 8.74M shares, a 5.01% increase year-over-year.
- LISATA THERAPEUTICS, INC. weighted average number of shares outstanding, diluted for fiscal 2025 was 8.69M shares, a 4.30% increase from fiscal 2024.
- LISATA THERAPEUTICS, INC. weighted average number of shares outstanding, diluted for fiscal 2024 was 8.33M shares, a 3.17% increase from fiscal 2023.
- LISATA THERAPEUTICS, INC. weighted average number of shares outstanding, diluted for fiscal 2023 was 8.07M shares, a 55.85% increase from fiscal 2022.
- LISATA THERAPEUTICS, INC. weighted average number of shares outstanding, diluted for fiscal 2022 was 5.18M shares, a 40.46% increase from fiscal 2021.
| Period end | Weighted Average Number of Shares Outstanding, Diluted 3 month | Weighted Average Number of Shares Outstanding, Diluted 3 month as first filed | Weighted Average Number of Shares Outstanding, Diluted 6 month | Weighted Average Number of Shares Outstanding, Diluted 6 month as first filed | Weighted Average Number of Shares Outstanding, Diluted 9 month | Weighted Average Number of Shares Outstanding, Diluted 9 month as first filed | Weighted Average Number of Shares Outstanding, Diluted 12 month | Weighted Average Number of Shares Outstanding, Diluted 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | 9.11M shares 10-Q · filed 2026-08-06 | 9.06M shares 10-Q · filed 2026-08-06 | 8.97M shares derived: average of 3 quarters · filed 2026-08-06 | 8.91M shares derived: average of 4 quarters · filed 2026-08-06 | ||||
| 2026-03-31 | 9.01M shares 10-Q · filed 2026-05-11 | 8.90M shares derived: average of 2 quarters · filed 2026-05-11 | 8.85M shares derived: average of 3 quarters · filed 2026-05-11 | 8.79M shares derived: average of 4 quarters · filed 2026-08-06 | ||||
| 2025-12-31 | 8.80M shares derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-12 | 8.77M shares derived: average of 2 quarters · filed 2026-03-12 | 8.71M shares derived: average of 3 quarters · filed 2026-08-06 | 8.69M shares 10-K · filed 2026-03-12 | ||||
| 2025-09-30 | 8.74M shares 10-Q · filed 2025-11-06 | 8.67M shares derived: average of 2 quarters · filed 2026-08-06 | 8.65M shares 10-Q · filed 2025-11-06 | 8.59M shares derived: average of 4 quarters · filed 2026-08-06 | ||||
| 2025-06-30 | 8.61M shares 10-Q · filed 2026-08-06 | 8.60M shares 10-Q · filed 2026-08-06 | 8.53M shares derived: average of 3 quarters · filed 2026-08-06 | 8.48M shares derived: average of 4 quarters · filed 2026-08-06 | ||||
| 2025-03-31 | 8.60M shares 10-Q · filed 2026-05-11 | 8.50M shares derived: average of 2 quarters · filed 2026-05-11 | 8.44M shares derived: average of 3 quarters · filed 2026-05-11 | 8.41M shares derived: average of 4 quarters · filed 2026-05-11 | ||||
| 2024-12-31 | 8.39M shares derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-12 | 8.36M shares derived: average of 2 quarters · filed 2026-03-12 | 8.34M shares derived: average of 3 quarters · filed 2026-03-12 | 8.33M shares 10-K · filed 2026-03-12 | ||||
| 2024-09-30 | 8.32M shares 10-Q · filed 2025-11-06 | 8.31M shares derived: average of 2 quarters · filed 2025-11-06 | 8.31M shares 10-Q · filed 2025-11-06 | 8.27M shares derived: average of 4 quarters · filed 2025-11-06 | ||||
| 2024-06-30 | 8.31M shares 10-Q · filed 2025-08-07 | 8.30M shares 10-Q · filed 2025-08-07 | 8.25M shares derived: average of 3 quarters · filed 2025-08-07 | 8.22M shares derived: average of 4 quarters · filed 2025-08-07 | ||||
| 2024-03-31 | 8.29M shares 10-Q · filed 2025-05-08 | 8.22M shares derived: average of 2 quarters · filed 2025-05-08 | 8.19M shares derived: average of 3 quarters · filed 2025-05-08 | 8.15M shares derived: average of 4 quarters · filed 2025-05-08 | ||||
| 2023-12-31 | 8.14M shares derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-27 | 8.14M shares derived: average of 2 quarters · filed 2025-02-27 | 8.10M shares derived: average of 3 quarters · filed 2025-02-27 | 8.07M shares 10-K · filed 2025-02-27 | ||||
| 2023-09-30 | 8.14M shares 10-Q · filed 2024-11-12 | 8.08M shares derived: average of 2 quarters · filed 2024-11-12 | 8.05M shares 10-Q · filed 2024-11-12 | 8.01M shares derived: average of 4 quarters · filed 2024-11-12 | ||||
| 2023-06-30 | 8.02M shares 10-Q · filed 2024-08-12 | 8.00M shares 10-Q · filed 2024-08-12 | 7.97M shares derived: average of 3 quarters · filed 2024-08-12 | 7.16M shares derived: average of 4 quarters · filed 2024-08-12 | ||||
| 2023-03-31 | 7.99M shares 10-Q · filed 2024-05-09 | 7.94M shares derived: average of 2 quarters · filed 2024-05-09 | 6.88M shares derived: average of 3 quarters · filed 2024-05-09 | 6.17M shares derived: average of 4 quarters · filed 2024-05-09 | ||||
| 2022-12-31 | 7.89M shares derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-29 | 6.32M shares derived: average of 2 quarters · filed 2024-02-29 | 5.56M shares derived: average of 3 quarters · filed 2024-02-29 | 5.18M shares 10-K · filed 2024-02-29 | ||||
| 2022-09-30 | 4.75M shares 10-Q · filed 2023-11-02 | 4.39M shares derived: average of 2 quarters · filed 2023-11-02 | 4.28M shares 10-Q · filed 2023-11-02 | 4.20M shares derived: average of 4 quarters · filed 2023-11-02 | ||||
| 2022-06-30 | 4.04M shares 10-Q · filed 2023-08-14 | 60.53M shares 10-Q · filed 2022-08-04 | 4.04M shares 10-Q · filed 2023-08-14 | 60.55M shares 10-Q · filed 2022-08-04 | 4.02M shares derived: average of 3 quarters · filed 2023-08-14 | 4.01M shares derived: average of 4 quarters · filed 2023-08-14 | ||
| 2022-03-31 | 4.04M shares 10-Q · filed 2023-05-09 | 60.56M shares 10-Q · filed 2022-05-05 | 4.01M shares derived: average of 2 quarters · filed 2023-05-09 | 4.00M shares derived: average of 3 quarters · filed 2023-05-09 | 17.88M shares derived: average of 4 quarters · filed 2023-05-09 | |||
| 2021-12-31 | 3.99M shares derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-30 | 3.98M shares derived: average of 2 quarters · filed 2023-03-30 | 22.49M shares derived: average of 3 quarters · filed 2023-03-30 | 3.69M shares 10-K · filed 2023-03-30 | 55.31M shares 10-K · filed 2022-03-22 | |||
| 2021-09-30 | 3.97M shares 10-Q · filed 2022-11-10 | 59.61M shares 10-Q · filed 2021-11-04 | 31.74M shares derived: average of 2 quarters · filed 2022-11-10 | 3.59M shares 10-Q · filed 2022-11-10 | 53.81M shares 10-Q · filed 2021-11-04 | 31.25M shares derived: average of 4 quarters · filed 2022-11-10 | ||
| 2021-06-30 | 59.51M shares 10-Q · filed 2022-08-04 | 50.86M shares 10-Q · filed 2022-08-04 | 40.35M shares derived: average of 3 quarters · filed 2022-08-04 | 34.91M shares derived: average of 4 quarters · filed 2022-08-04 | ||||
| 2021-03-31 | 42.12M shares 10-Q · filed 2022-05-05 | 30.76M shares derived: average of 2 quarters · filed 2022-05-05 | 26.71M shares derived: average of 3 quarters · filed 2022-05-05 | 23.32M shares derived: average of 4 quarters · filed 2022-05-05 | ||||
| 2020-12-31 | 19.41M shares derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-22 | 19.00M shares derived: average of 2 quarters · filed 2022-03-22 | 17.05M shares derived: average of 3 quarters · filed 2022-03-22 | 15.44M shares 10-K · filed 2022-03-22 | ||||
| 2020-09-30 | 18.60M shares 10-Q · filed 2021-11-04 | 15.87M shares derived: average of 2 quarters · filed 2021-11-04 | 14.12M shares 10-Q · filed 2021-11-04 | |||||
| 2020-06-30 | 13.15M shares 10-Q · filed 2021-08-05 | 11.88M shares 10-Q · filed 2021-08-05 | ||||||
| 2020-03-31 | 10.62M shares 10-Q · filed 2021-05-06 | |||||||
| 2018-12-31 | 9.69M shares 10-K · filed 2019-03-14 | |||||||
| 2017-12-31 | 8.97M shares 10-K · filed 2019-03-14 | 8.97M shares 10-K · filed 2018-03-22 | ||||||
| 2016-12-31 | 6.55M shares 10-K · filed 2018-03-22 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Vistagen Therapeutics, Inc. (VTGN) | United States | $0.013B | -0.14 |
| MUSTANG BIO, INC. (MBIO) | United States | $0.013B | |
| BullFrog AI Holdings, Inc. (BFRG) | United States | $0.014B | |
| AEON Biopharma, Inc. (AEON) | United States | $0.013B | -0.36 |
| Vyome Holdings, Inc (HIND) | United States | $0.014B | -1.38 |
| Tvardi Therapeutics, Inc. (TVRD) | United States | $0.014B | |
| Tempest Therapeutics, Inc. (TPST) | United States | $0.013B | |
| Aspire Biopharma Holdings, Inc. (ASBP) | United States | $0.012B | -0.60 |
| ACTUATE THERAPEUTICS, INC. (ACTU) | United States | $0.015B | |
| BIOVIE INC. (BIVI) | United States | $0.012B |